se·je·las
/ˌ səjəˈlas /
Origin: Malay
Adjective: clear, transparent, luminous, translucent
Sejelas is a recruitment consultancy offering bespoke talent acquisition services for the finance and life science industries.
Whether you are a company that needs help hiring the right people or a professional looking to advance your career, we are committed to supporting you with your search.
se·je·las
/ˌ səjəˈlas /
Origin: Malay
Adjective: clear, transparent, luminous, translucent
Sejelas is a recruitment consultancy offering bespoke talent acquisition services for the Life Science and Finance industries.
Whether you are a company that needs help hiring the right people or a professional looking to advance your career, we are committed to supporting you with your search.
se·je·las
/ˌ səjəˈlas /
Origin: Malay
Adjective: clear, transparent, luminous, translucent
Your Partner in Life Science & Finance Recruitment
What we do
We are the right partner to help recruit primarily in the following areas:
EXECUTIVE SEARCH
Recruiting the right executive leader can be one of the most challenging tasks a company can face.
Whether searching for Board Members, C-Level Officers or Senior Management, our well-maintained network and personal approach ensures our clients will have access to a diverse blend of skills and experience that matches the strategic direction of their organisations.
We serve a wide variety of companies from early stage start-ups to large public companies.
Life Sciences
Translational Research, R&D Project Management, Clinical Development & Operations, Medicinal Chemistry, Discovery Biology, Bio-Cheminformatics, Toxicology, Data Science, Business Intelligence, Digital Transformation, Digital Health, Commercial, Marketing, Sales, Business Development, Market Access, Medical Affairs
Finance
Investment Analysis and Management, Controlling, Mergers & Acquisitions, Corporate Finance, Strategy, Corporate Development, Risk Management, Transformation, Restructuring, Investor Relations, Controlling, Accounting, Financial Planning & Analysis, Audit, Human Resource, Recruitment, Operations
Clients
What do our customers say?
Making your next career move is an important step
We pride ourselves in supporting you to find the right opportunity that fulfills your ambitions, allowing you to make the right change, at the right time, to the right place.
Insights
The latest interviews and articles from Sejelas
Stephan Christgau
You have an extensive background in both academia and the biotech industry, with over 60 peer-reviewed papers and multiple patents. How has your experience as a researcher shaped your approach as a life sciences investor and entrepreneur?
I think it gives a different perspective as an investor, when you have actually had operational experience. Having started companies and worked with f.ex. patent strategy, development plans and CRO selection and monitoring is not only something I hear about in the board room, but something I have actually done myself.
That said, one should of course also be humble and recognize that one’s own experience is only directly relevant in few cases, and of course we engage experts and other stakeholders in all cases, but it is nevertheless a different perspective one gets from having started and run companies.
The scientific background, and ability to grasp and challenge scientific backgrounds of projects and companies, is essential for an investor in the life science space, and indeed I believe most of my peers in other venture funds have scientific and/or clinical backgrounds.
John Boghossian
Can you share the inspiration and vision behind founding Kadence Bio?
The inspiration for Kadence Bio stemmed from our founders’ early investigations into potential acute treatments for mood disorders, where they explored different classes of alkaloid small molecules. We discovered a compound scaffold with a distinctive pharmacokinetic profile that also exhibited an unexpected effect of delayed ejaculation. This – rather unexpected! – The finding was corroborated by the elucidation of its potential mechanism of action.
We then identified a significant unmet need, as no FDA-approved treatments exist for premature ejaculation, a condition that affects at least 1 in 20 men and their partners globally and hinders intimacy and well-being in these relationships. We quickly decided to found Kadence Bio, with a vision of cultivating sexual and mental well-being by developing novel treatments for sexual health and mood disorder applications.
